Analyst Consensus
- Current Price
- 228.39 $
- Target (Low)
- 155.00 $
- Target (Mean)
- 252.87 $
- Target (High)
- 285.00 $
- Recommendation
- Buy
- Number of Analysts
- 23
Recommendation Distribution
Recommendation Distribution| Strong Buy | 5 |
|---|
| Buy | 10 |
|---|
| Hold | 8 |
|---|
| Sell | 0 |
|---|
| Strong Sell | 1 |
|---|
Key Ratios
- Net Profit Margin
- 21.8%
- Operating Margin
- 27.4%
- Gross Margin
- 68.0%
- Return on Equity (ROE)
- 26.4%
- Return on Assets (ROA)
- 8.4%
- Revenue Growth
- 9.9%
- Earnings Growth
- -52.9%
- Debt/Equity
- 67.73
- Current Ratio
- 1.03
- Beta
- 0.26
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| May 13, 2026 | Leerink Partners | Market Perform → Outperform |
| Apr 15, 2026 | Barclays | Equal-Weight → Equal-Weight |
| Apr 15, 2026 | Stifel | Hold → Hold |
| Apr 15, 2026 | Wells Fargo | Overweight → Overweight |
| Apr 10, 2026 | Morgan Stanley | Overweight → Overweight |
| Mar 30, 2026 | RBC Capital | Outperform → Outperform |